157 related articles for article (PubMed ID: 2960611)
1. Selective effects of vasoactive intestinal peptide on the mitogenic response of murine T cells.
Ottaway CA
Immunology; 1987 Oct; 62(2):291-7. PubMed ID: 2960611
[TBL] [Abstract][Full Text] [Related]
2. Modulation of T lymphocyte proliferation in mice infected with Schistosoma mansoni: VIP suppresses mitogen- and antigen-induced T cell proliferation possibly by inhibiting IL-2 production.
Metwali A; Blum A; Mathew R; Sandor M; Lynch RG; Weinstock JV
Cell Immunol; 1993 Jun; 149(1):11-23. PubMed ID: 8099848
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of mouse T-cell proliferation by CGRP and VIP: effects of these neuropeptides on IL-2 production and cAMP synthesis.
Boudard F; Bastide M
J Neurosci Res; 1991 May; 29(1):29-41. PubMed ID: 1653367
[TBL] [Abstract][Full Text] [Related]
4. Interaction of vasoactive intestinal peptide with mouse lymphocytes: specific binding and the modulation of mitogen responses.
Ottaway CA; Greenberg GR
J Immunol; 1984 Jan; 132(1):417-23. PubMed ID: 6606671
[TBL] [Abstract][Full Text] [Related]
5. Vasoactive intestinal peptide stimulates T lymphocytes to release IL-5 in murine schistosomiasis mansoni infection.
Mathew RC; Cook GA; Blum AM; Metwali A; Felman R; Weinstock JV
J Immunol; 1992 Jun; 148(11):3572-7. PubMed ID: 1588046
[TBL] [Abstract][Full Text] [Related]
6. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide-38 inhibit IL-10 production in murine T lymphocytes.
Martinez C; Delgado M; Gomariz RP; Ganea D
J Immunol; 1996 Jun; 156(11):4128-36. PubMed ID: 8666779
[TBL] [Abstract][Full Text] [Related]
7. Vasoactive intestinal peptide inhibits IL-4 production in murine T cells by a post-transcriptional mechanism.
Wang HY; Xin Z; Tang H; Ganea D
J Immunol; 1996 May; 156(9):3243-53. PubMed ID: 8617946
[TBL] [Abstract][Full Text] [Related]
8. Modulation of T lymphocyte function by neuropeptides. Evidence for their role as local immunoregulatory elements.
Nio DA; Moylan RN; Roche JK
J Immunol; 1993 Jun; 150(12):5281-8. PubMed ID: 8515059
[TBL] [Abstract][Full Text] [Related]
9. Concanavalin A triggers T lymphocytes by directly interacting with their receptors for activation.
Palacios R
J Immunol; 1982 Jan; 128(1):337-42. PubMed ID: 6459373
[TBL] [Abstract][Full Text] [Related]
10. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Feb; 162(3):1707-16. PubMed ID: 9973433
[TBL] [Abstract][Full Text] [Related]
11. Human T lymphocyte chemotaxis and adhesion induced by vasoactive intestinal peptide.
Johnston JA; Taub DD; Lloyd AR; Conlon K; Oppenheim JJ; Kevlin DJ
J Immunol; 1994 Aug; 153(4):1762-8. PubMed ID: 7519212
[TBL] [Abstract][Full Text] [Related]
12. VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4(+) T cells.
Delgado M; Reduta A; Sharma V; Ganea D
J Leukoc Biol; 2004 Jun; 75(6):1122-30. PubMed ID: 15020654
[TBL] [Abstract][Full Text] [Related]
13. Positively selected Lyt-2+ and Lyt-2- mouse T lymphocytes are comparable, after Con A stimulation, in release of IL 2 and of lymphokines acting on B cells, macrophages, and mast cells, but differ in interferon production.
Guerne PA; Piguet PF; Vassalli P
J Immunol; 1983 May; 130(5):2225-30. PubMed ID: 6187845
[TBL] [Abstract][Full Text] [Related]
14. Pyrimidinone (bropirimine) mediated alteration of T lymphocyte subsets during murine cytomegalovirus infection.
Brideau RJ; Nicholas JA
Clin Exp Immunol; 1987 Jun; 68(3):613-20. PubMed ID: 2820635
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive intestinal peptide downregulates the expression of IL-2 but not of IFN gamma from stimulated murine T lymphocytes.
Ganea D; Sun L
J Neuroimmunol; 1993 Sep; 47(2):147-58. PubMed ID: 8103776
[TBL] [Abstract][Full Text] [Related]
16. Restricted expression of mitogen-induced high affinity IL-2 receptors in aging mice.
Proust JJ; Kittur DS; Buchholz MA; Nordin AA
J Immunol; 1988 Dec; 141(12):4209-16. PubMed ID: 3264308
[TBL] [Abstract][Full Text] [Related]
17. Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide.
Pozo D; Anderson P; Gonzalez-Rey E
J Immunol; 2009 Oct; 183(7):4346-59. PubMed ID: 19734220
[TBL] [Abstract][Full Text] [Related]
18. Macrophage inflammatory protein-1 alpha rapidly modulates its receptors and inhibits the anti-CD3 mAb-mediated proliferation of T lymphocytes.
Zhou Z; Kim YJ; Pollok K; Hurtado J; Lee JK; Broxmeyer HE; Kwon BS
J Immunol; 1993 Oct; 151(8):4333-41. PubMed ID: 8409405
[TBL] [Abstract][Full Text] [Related]
19. Transduction of specific inhibition of HuT 78 human T cell chemotaxis by type I vasoactive intestinal peptide receptors.
Xia M; Gaufo GO; Wang Q; Sreedharan SP; Goetzl EJ
J Immunol; 1996 Aug; 157(3):1132-8. PubMed ID: 8757618
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of cyclosporin A on the expression of T and B lymphocyte activation antigens.
Lillehoj HS; Malek TR; Shevach EM
J Immunol; 1984 Jul; 133(1):244-50. PubMed ID: 6327823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
